An inhibitor of Hsp70, Hsc70, and GRP78
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

VER-155008

Item No. 17257

Technical Information
Formal Name
5'-O-[(4-cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl)methyl]amino]-adenosine
CAS Number
1134156-31-2
Molecular Formula
C25H23Cl2N7O4
Formula Weight
Purity
≥95%
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2) (1:9): 0.1 mg/ml
λmax
216, 275 nm
SMILES
O[C@H]1[C@@H](O)[C@H](N2C(NCC3=CC=C(Cl)C(Cl)=C3)=NC4=C2N=CN=C4N)O[C@@H]1COCC5=CC=C(C#N)C=C5
InChi Code
InChI=1S/C25H23Cl2N7O4/c26-16-6-5-15(7-17(16)27)9-30-25-33-19-22(29)31-12-32-23(19)34(25)24-21(36)20(35)18(38-24)11-37-10-14-3-1-13(8-28)2-4-14/h1-7,12,18,20-21,24,35-36H,9-11H2,(H,30,33)(H2,29,31,32)/t18-,20-,21-,24-/m1/s1
InChi Key
ZXGGCBQORXDVTE-UMCMBGNQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    VER-155008 is an inhibitor of heat shock protein 70 (Hsp70), heat shock cognate 71 kDa protein (Hsc70), and glucose-regulated protein 78 kDa (GRP78), also known as heat shock 70 kDa protein 5 (HspA5) or immunoglobulin heavy chain-binding protein (BiP; IC50s = 0.5, 2.6, and 2.6 µM, respectively).1 It inhibits the ATPase activity of Hsp70 and is selective for Hsp70, Hsc70, and GRP78 over Hsp90 (IC50 = >200 µM). VER-155008 reduces proliferation of BT474 breast cancer, HCT116 colorectal cancer, and HT-29 colorectal cancer cells (GI50s = 10.4, 5.3, and 12.8 µM, respectively). It induces degradation of the Hsp90 client proteins HER2 and C-RAF in BT474 and HCT116 cells, apoptosis in HCT116 cells, and paraptosis in FRO and 8505C anaplastic thyroid carcinoma cells.1,2 VER-155008 reduces tumor volume in a PC12 pheochromocytoma mouse xenograft model and rescues memory deficits in a 5XFAD transgenic mouse model of Alzheimer’s disease.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Massey, A.J., Williamson, D.S., Browne, H., et alA novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother. Pharmacol. 66(3), 535-545 (2015).

    2. Kim, S.H., Kang, J.G., Kim, C.S., et alThe hsp70 inhibitor VER155008 induces paraptosis requiring de novo protein synthesis in anaplastic thyroid carcinoma cells. Biochim. Biophys. Acta 454(1), 36-41 (2014).

    3. Xu, F., Lin, D., Jiang, W., et alHSP70 inhibitor VER155008 suppresses pheochromocytoma cell and xenograft growth by inhibition of PI3K/AKT/mTOR and MEK/ERK pathways. Int. J. Clin 12(7), 2585-2594 (2019).

    4. Yang, X., and Tohda, C. Heat shock cognate 70 inhibitor, VER-155008, reduces memory deficits and axonal degeneration in a mouse model of Alzheimer’s disease. Front. Pharmacol. 9, 48 (2018).